Skip to main content
. 2022 Apr 27;13:875887. doi: 10.3389/fphar.2022.875887

TABLE 3.

Lymphoid populations (absolute counts) in the lung of SP-CI73TGATA1WT and SP-CI73TGATA1KO mice.

Lymphoid Genotype CTL (n=6) 7d (n=5) 14d (n=4) 42d (n=4)
Total Lymphocytes CD3+ SPCI73TGATA1WT 345,631 ± 86,296 183,554 ± 39,269 395,329 ± 56,594 190,527 ± 65,449
SPCI73TGATA1KO 250,269 ± 79,960 360,842 ± 47,500 589,159 ± 253,538 126,307 ± 25,065 c
T Cells CD3+CD4+ SPCI73TGATA1WT 195,017 ± 54,159 69,888 ± 14,055 143,506 ± 17,513 82,764 ± 28,488
SPCI73TGATA1KO 96,382 ± 29,041 160,060 ± 22,763 261,151 ± 119,068 64,875 ± 12,762
T Cells CD3+CD8+ SPCI73TGATA1WT 56,669 ± 14,499 42,242 ± 10,950 89,201 ± 7,790 34,887 ± 12,703
SPCI73TGATA1KO 81,096 ± 27,228 75,407 ± 1,942 146,561 ± 78,064 18,951 ± 4,028 c
Dendritic Cells CD4+CD103+ SPCI73TGATA1WT 5,220 ± 1,415 4,584 ± 1,254 61,332 ± 22,982 a , b 6,324 ± 2,890 c
SPCI73TGATA1KO 1,894 ± 549 20,495 ± 10,423 25,963 ± 8,265 4,703 ± 722
Dendritic Cells CD8+CD103+ SPCI73TGATA1WT 63,210 ± 14,376 46,197 ± 13,312 24,085 ± 2,449 42,933 ± 14,522
SPCI73TGATA1KO 39,530 ± 15,995 66,423 ± 7,023 55,100 ± 30,155 20,219 ± 4,546
Total B Cells B220+ SPCI73TGATA1WT 355,729 ± 116,677 121,006 ± 36,745 174,755 ± 42,299 185,453 ± 74,308
SPCI73TGATA1KO 575,678 ± 176,291 277,739 ± 66,428 380,566 ± 195,524 79,770 ± 17,796 a
B Cells B220+CX3CR1- SPCI73TGATA1WT 136,526 ± 50,823 34,278 ± 12,104 105,394 ± 18,429 79,686 ± 33,316
SPCI73TGATA1KO 161,705 ± 47,002 105,698 ± 40,083 75,482 ± 42,431 10,523 ± 2,139 a
B Cells B220+CX3CR1+ SPCI73TGATA1WT 266,498 ± 75,310 86,729 ± 24,875 69,362 ± 26,868 105,766 ± 41,078
SPCI73TGATA1KO 413,972 ± 129,402 172,040 ± 27,728 262,333 ± 170,944 69,247 ± 15,758 a

Single cell suspensions of SP-CI73TGATA1WT and SP-CI73TGATA1KO lung digests was assessed by flow cytometry, enriched in viable CD45+ singlets, and analyzed following gating strategy described in the Methods section. Absolute counts are presented as means ± SEM (N=4-6 mice/condition). Data were analyzed by two-way ANOVA, with Tukey post-hoc test.

aSignificant compared to controls (CTL).

bSignificant compared to 7 d group.

cSignificant compared to 14 d group.